| Literature DB >> 33426195 |
Gülden Küçükakça Çelik1, Hatice Çakır2, Engin Kut3.
Abstract
OBJECTIVE: This study aimed to investigate the mediating role of social support in the relationship between resilience and quality of life (QoL) among Turkish patients with early-stage breast cancer.Entities:
Keywords: Breast cancer; Quality of life; psychological resilience; social support
Year: 2020 PMID: 33426195 PMCID: PMC7785076 DOI: 10.4103/apjon.apjon_44_20
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Figure 1The mediation model of social support for the relationship between resilience and QLQ (EORTC QLQ-BR23: FS). “+” The first step represents social support regressed on resilience. “++” The second step represents quality of life regressed on resilience. “+++” The third step represents quality of life regressed on resilience and social support. EORTC QLQ-BR23: FS: European Organization for Research and Treatment of Cancer Quality of Life Breast Cancer Module: Functional Scale
Figure 2The mediator model of social support for the relationship between resilience and QLQ (EORTC QLQ-BR23: SC). “+” The first step represents social support regressed on resilience. “++” The second step represents quality of life regressed on resilience. “+++” The third step represents quality of life regressed on resilience and social support. EORTC QLQ-BR23: SC: European Organization for Research and Treatment of Cancer Quality of Life Breast Cancer Module: Symptom Scale
Figure 3Structural equation model of social support mediating the relationship between resilience and QLQ (EORTC QLQ-C30). Standardized estimates for significant paths at P < 0.05 are presented. FA: Family, FR: Friends, FS: Functional Scale, GHS: General health status, O: Other (special person), SC: Symptom scale, SS: Social support, TNE: Tolerance of negative affect, TPC: Tenacity and personal competence, TTS: Tendency toward spirituality, EORTC QLQ: European Organization for Research and Treatment of Cancer Quality of Life
Participants' demographic and disease characteristics (n=113)
| Characteristics | % | |
|---|---|---|
| Age (years) | ||
| 18-40 | 11 | 9.7 |
| 41-50 | 46 | 40.7 |
| 51-60 | 27 | 23.9 |
| 61 and older | 29 | 25.7 |
| Marital status | ||
| Married | 94 | 83.2 |
| Single | 19 | 16.8 |
| Education level | ||
| Below primary school | 28 | 24.8 |
| Primary school | 61 | 54.0 |
| High school | 21 | 18.5 |
| University or higher | 3 | 2.7 |
| Children | ||
| Yes | 103 | 91.2 |
| No | 10 | 8.8 |
| People living together | ||
| Living alone | 5 | 4.4 |
| Living with family | 108 | 95.6 |
| Employed | ||
| Yes | 5 | 4.4 |
| No | 108 | 95.6 |
| Income status | ||
| Sufficient | 9 | 8.0 |
| Middle | 65 | 57.5 |
| Insufficient | 39 | 34.5 |
| Employment status | ||
| Currently working | 6 | 5.3 |
| Retired | 4 | 3.5 |
| Homemaker | 103 | 91.2 |
| Getting information about breast cancer before diagnosis | ||
| Yes | 21 | 18.6 |
| No | 92 | 81.4 |
| Information sources ( | ||
| Health-care professionals | 12 | 57.1 |
| The internet | 5 | 23.8 |
| Other people | 4 | 19.0 |
| First-degree relative breast cancer | ||
| Yes | 10 | 8.8 |
| No | 103 | 91.2 |
| Chronic disease | ||
| Yes | 38 | 33.6 |
| No | 75 | 66.4 |
| BMI (kg/m2) | ||
| Normal weight (18.5-24.9) | 10 | 17.7 |
| Overweight (25-29-9) | 44 | 38.9 |
| Obese (≥30) | 49 | 43.4 |
| Time since diagnosis | ||
| <1 year | 45 | 39.8 |
| Between 1 and 2 years | 35 | 31.0 |
| Between 2 and 5 years | 33 | 29.2 |
| Stage of breast cancer | ||
| Stage 1 | 31 | 27.4 |
| Stage 2 | 82 | 72.6 |
| Surgery | ||
| Yes | 96 | 85.0 |
| No | 17 | 15.0 |
| Surgery type ( | ||
| Simple mastectomy | 3 | 3.1 |
| Radical mastectomy | 42 | 43.8 |
| Skin-conserving surgery | 4 | 4.2 |
| Breast-conserving surgery | 47 | 49.0 |
| Treatment type ( | ||
| Chemotherapy | 40 | 40.0 |
| Radiotherapy | 5 | 5.0 |
| Chemotherapy + radiotherapy | 54 | 54.0 |
| Hormone therapy | 1 | 1.0 |
BMI: Body mass index
Correlation matrix for resilience, social support, and quality of life (n=113)
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1- EORTC QLQ-C30: FS | 1.000 | ||||||||||||
| - | |||||||||||||
| 2- EORTC QLQ-C30: GHS | -0.420 | 1.000 | |||||||||||
| 0.000** | - | ||||||||||||
| 3- EORTC QLQ-C30: SC | 0.646 | -0.433 | 1.000 | ||||||||||
| 0.000** | 0.000** | - | |||||||||||
| 4- EORTC BR23: FS | 0.342 | -0.226 | 0.348 | 0.363 | 1.000 | ||||||||
| 0.000** | 0.000** | 0.000** | 0.000** | - | |||||||||
| 5- EORTC BR23: SC | 0.679 | −0.445 | 0.750 | 0.752 | 0.340 | 1.000 | |||||||
| 0.000** | 0.000** | 0.000** | 0.000** | 0.000** | - | ||||||||
| 6- TPC | −0.007 | 0.064 | 0.016 | 0.016 | −0.316 | −0.045 | −0.170 | 1.000 | |||||
| 0.940 | 0.501 | 0.868 | 0.868 | 0.001** | 0.636 | 0.071 | - | ||||||
| 7- TNE | −0.086 | 0.045 | −0.079 | −0.089 | −0.217 | −0.089 | −0.162 | 0.583 | 1.000 | ||||
| 0.363 | 0.639 | 0.407 | 0.347 | 0.021* | 0.348 | 0.087 | 0.000** | - | |||||
| 8- TTS | 0.004 | −0.014 | −0.021 | −0.011 | −0.200 | −0.012 | −0.095 | 0.579 | 0.369 | 1.000 | |||
| 0.968 | 0.883 | 0.824 | 0.909 | 0.034* | 0.897 | 0.316 | 0.000** | 0.000** | - | ||||
| 9- CDPRS-25 Total | −0.038 | 0.056 | −0.025 | −0.027 | −0.321 | −0.065 | −0.184 | 0.937 | 0.814 | 0.650 | 1.000 | ||
| 0.688 | 0.559 | 0.796 | 0.774 | 0.000** | 0.492 | 0.051 | 0.000** | 0.000** | 0.000** | - | |||
| 10- FA | −0.145 | 0.180 | −0.057 | −0.092 | −0.152 | −0.132 | −0.167 | 0.003 | 0.038 | 0.161 | 0.040 | 1.000 | |
| 0.126 | 0.056 | 0.546 | 0.334 | 0.107 | 0.162 | 0.077 | 0.978 | 0.691 | 0.089 | 0.678 | - | ||
| 11- FR | −0.239 | 0.093 | −0.002 | −0.146 | −0.127 | −0.079 | −0.116 | 0.163 | 0.077 | 0.070 | 0.142 | 0.422 | 1.000 |
| 0.011* | 0.325 | 0.985 | 0.123 | 0.179 | 0.404 | 0.223 | 0.085 | 0.417 | 0.458 | 0.133 | 0.000** | - | |
| 12- O | −0.223 | 0.111 | 0.007 | −0.127 | −0.088 | −0.043 | −0.071 | 0.110 | 0.037 | 0.026 | 0.087 | 0.396 | 0.945 |
| 0.018* | 0.243 | 0.945 | 0.181 | 0.353 | 0.651 | 0.455 | 0.246 | 0.698 | 0.78 | 0.360 | 0.000** | 0.000** | |
| 13- MPSSS Total | −0.232 | 0.120 | −0.031 | −0.151 | −0.139 | −0.128 | −0.158 | 0.094 | 0.038 | 0.055 | 0.082 | 0.587 | 0.923 |
| 0.013* | 0.207 | 0.744 | 0.111 | 0.141 | 0.177 | 0.094 | 0.321 | 0.691 | 0.562 | 0.390 | 0.000** | 0.000** |
*P<0.05, **P<0.001. CDPRS 25: Connor-Davidson Psychological Resilience Scale 25, EORTC QLQ-BR23: European Organization for Research and Treatment of Cancer Quality of Life Breast Cancer Module 23, EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, MPSSS: Multidimensional Perceived Social Support Scale, FA: Family, FR: Friends, FS: Functional scale, GHS: General health status, O: Other (special person), SC: Symptom scale, TNE: Tolerance of negative effect, TPC: Tenacity and personal competence, TTS: Tendency toward spirituality
Mediating effect of social support on quality of life (EORTC BR23)
| Mediating effect of social support | Total effect | Direct effect | Mediation effect | Bootstrap confidence interval (BootLLCI.BootMULCI) | Mediating effect | |
|---|---|---|---|---|---|---|
| CDPRS 25- EORTC QLQ-BR23: FS | −0.0601 | −0.0566 | −0.003* | −0.0155-0.0024 | 0.102 | Partial effect |
| CDPRS 25- EORTC QLQ-BR23: SC | −0.017 | −0.013 | −0.0007 | −0.0033-0.0010 | 0.0154 | Reject |
*P<0.05. CDPRS 25: Connor-Davidson Psychological Resilience Scale 25, EORTC QLQ-BR23: European Organization for Research and Treatment of Cancer Quality of Life Breast Cancer Module 23, FS: Functional scale, SC: Symptom scale, LLCI: Lower Limit of the Confidence Interval, ULCI: Upper Limit of the Confidence Interval
Hypothesis results in the context of structural equation modeling model of research
| Effect | Estimation | Standard error | Results | ||
|---|---|---|---|---|---|
| R → SS | 0.206 | 0.149 | 1.378 | 0.168 | Reject |
| SS → EORTC QLQ-C30 | −0.056 | 0.059 | −0.955 | 0.339 | Reject |
| R → EORTC QLQ-C30 | −0.028 | 0.083 | −0.337 | 0.736 | Reject |
Compliance indexes: χ2/df=2.095; AGFI=0.460; CFI=0.664; GFI=0.495; NFI=0.512; IFI=0.667; RMSEA=0.099. EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, R: Resistance, SS: Social support, AGFI: Adjusted Goodness of Comparative Fit Index, GFI: Goodness-of-Fit Index, CFI: Comparative Fit Index, IFI: Incremental Fit Index, NFI: Normed Fit Index, RMSEA: Root mean square error of approximation